FDA approves Abbott's Aveir VR Mini, a smaller leadless pacemaker offering more implant options for patients with slow heart ...
12-month follow-up data demonstrates that the world’s first leadless pacemaker is having overall device performance comparable to conventional pacemakers. The miniature-sized, leadless cardiac ...
The newly approved device is 14% shorter than the previous version and gives clinicians more options when making implant ...
Single-chamber ventricular leadless pacemakers do not support atrial pacing or consistent atrioventricular synchrony. A dual-chamber leadless pacemaker system consisting of two devices implanted ...
The Aveir VR Mini ventricular leadless pacemaker [Image courtesy of Abbott]Abbott (NYSE: ABT) announced today that the FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results